ScreenerHero

ARTLArtelo Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · artelobio.com
0.6920USD-3.89%Mkt Cap: 3.18M $P/E: —

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap3.18M $
Enterprise Value-875.47K $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-12.88M $
Revenue/Share—
Last Price0.6920 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.81
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.60
EPS (TTM)-11.11
EPS (Forward)-0.88
52W Range
0.68030% of range31.65
52W High31.65 USD
52W Low0.6803 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE1012.50%
ROA-459.80%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.52M $
CapEx (TTM)—
FCF Margin—
FCF Yield-269.59%
Net Debt-4.15M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.53
Current Ratio3.00
Quick Ratio2.88
Book Value/Sh1.193 USD
Cash/Share0.9140 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 21, 2019
Splits
Last Split1:3
Split DateMar 10, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.60M
Float4.59M
Insiders1.88%
Institutions7.68%
Short Interest
Short Ratio0.6d
Short % Float3.88%
Short % Out.3.88%
Shares Short135.12K
Short (prev mo.)195.94K
Technical
SMA 501.004 (-31.0%)
SMA 2003.597 (-80.8%)
Beta-0.07
S&P 52W Chg18.16%
Avg Vol (30d)394.45K
Avg Vol (10d)876.71K
Technical Indicators
RSI (14)30.4
MACD-0.1081
MACD Signal-0.1236
MACD Hist.+0.0155
BB Upper1.012 USD
BB Middle0.7908 USD
BB Lower0.5700 USD
BB Width55.85%
ATR (14)0.0800 USD
Vol Ratio (20d)0.22x